Effect of hyperglycaemia at admission on 1-year mortality in Cox regression analysis
| Variable | Unadjusted HR (95% CI) | P value | Adjusted HR (95% CI) | P value | ||
| (Glucose_0, mg/dL) | HR | HR (95% CI) | HR | HR (95% CI) | ||
| Diabetes | ||||||
| <224.5 (n=376) | Ref. | Ref. | ||||
| ≥224.5 (n=173) | 1.83 | 1.83 (1.31 to 2.56) | < 0.001 | 1.35 | 1.35 (0.93 to 1.95) | 0.113 |
| Non-diabetes | ||||||
| <139.5 (n=850) | Ref. | Ref. | ||||
| ≥139.5 (n=628) | 2.32 | 2.32 (1.88 to 2.86) | < 0.001 | 1.47 | 1.47 (1.18 to 1.82) | 0.001 |
Adjusted gender, smoking status, hypertension, heart failure, hyperlipidaemia, ventricular arrhythmia, cerebral infarction, angiotensin-converting enzyme inhibitor use, insulin use, clopidogrel use, creatinine and sequential organ failure assessment score.
Glucose_0, admission blood glucose; Ref, reference.